Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-27
2007-02-27
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S171000
Reexamination Certificate
active
09316313
ABSTRACT:
The present invention a novel use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine in the treatment and controlling the spread of malaria. In particular, the present invention discloses a method of treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as a gametocytocidal agent.
REFERENCES:
patent: 2187847 (1940-01-01), Andersag
patent: 5104885 (1992-04-01), Nodiff
Bhat B et al. Indian J. Chem. Sect. B (1981), 20B(8), 703-5.
Puri et al. Am. J. Trop. Med. Hyg., 1989, 41(6):638-642.
Puri et al., Methemoglobin Toxicity and Hematological Studies on Malaria Anti-Relapse Compound CDRI 80/53 in Dogs, Am. J. Trop. Med Hyg., 41(6):638-642 (1989).
Saxena ,N. et al.“Effect of a new 8-Aminoquinoline Antimalarial compound on Hepatic . . . ” Indian Journal of Medical Research Section A Infectious Diseases, Sep. 1989 (330-333).
Paliwal, J.K. et al. “Simultaneous determination of a new Antimalarial agent . . . ” Journal of Chromatography, (1993) pp. 155-160.
Olliaro P.L. et al. “Status of Antimalarial drugs under development.” Bulletin of the World Health Organization, (1995) pp. 565-571.
Asthana Omkar Prasad
Bhaduri Amiya Prasad
Dutta Guru Prasad
Dwivedi Anil Kumar
Gupta Ram Chandra
Balls R. James
Chang Celia
Council of Scientific and Industrial Research
Ladas and Parry LLP
LandOfFree
Method for the treatment of malaria by the use of primaquine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of malaria by the use of primaquine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of malaria by the use of primaquine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3890798